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Electron microscopyCTP:phosphocholine cytidylyltransferase (CCT) is an amphitropic protein regulating phosphatidylcholine
synthesis. Lipid-induced folding of its amphipathic helical (AH) membrane-binding domain activates the en-
zyme. In this study we examined the membrane deforming property of CCT in vitro by monitoring conversion
of vesicles to tubules, using transmission electron microscopy. Vesicle tubulation was proportional to the
membrane density of CCT and proceeded either as growth from a pre-formed surface bud, or as a global
transformation of roughly spherical vesicles into progressively thinner tubules. The tubulation pathway
depended on the lipid compositional heterogeneity of the vesicles, with heterogeneous mixtures supporting
the bud-extension pathway. Co-existence of vesicles alongside thick and thin tubules suggested that CCT can
discriminate between ﬂat membrane surfaces and those with emerging curvature, binding preferentially to
the latter. Thin tubules had a limiting diameter of ~12 nm, likely representing bilayer cylinders with a very
high density of 1 CCT/50 lipids. The AH segment was necessary and sufﬁcient for tubulation. AH regions
from diverse CCT sources, including C. elegans, had tubulation activity that correlated with α-helical length.
The AH motifs in CCT and the Parkinson's-related protein, α-synuclein, have similar features, however the
CCT AH was more effective in its membrane remodeling function. That CCT can deform vesicles of physiolog-
ically relevant composition suggests that CCT binding to membranes may initiate deformations required for
organelle morphogenesis and at the same time stimulate synthesis of the PC required for the development of
these regions.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The amphipathic helix (AH) is a membrane binding motif utilized
by many peripheral or amphitropic proteins [1]. Aside from their
function in anchoring proteins to membranes, there is a growing ap-
preciation of an additional feature of AH segments: they bend bilayers
upon insertion [2]. When the AH segment partitions into the bilayer it
occupies only the proximal monolayer, usually at a position centeredsferase; AH, amphipathic helix;
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rights reserved.within the interfacial zone of the proximal leaﬂet. This asymmetric lo-
cation of the bound AH impacts on the lipid packing pressure proﬁle
across the bilayer resulting in positive curvature induction [3]. In an
elastic anisotropic medium such as a phospholipid bilayer the expan-
sion of a monolayer by the inserted AH will be related to surface den-
sity of the AH, the elasticity of the lipid being expanded, and the
degree of displacement of lipids by the AH [3]. Curling the proximal
monolayer will also curl the distal monolayer (in the opposite man-
ner) because there is tight transverse coupling due to the necessity
of maintaining the connection where the acyl chains meet. Although
the basic physics of AH-induced membrane bending has been well
described, some determinants of curvature induction require further
investigation, such as how curvature induction is impacted by the
lipid composition, or by properties of the AH such as its length, hydro-
phobicity, amphipathy, or its embedded position in the bilayer.
One of the clearest examples of the function of membrane remo-
deling by an AH motif is in the process of endocytosis. Proteins like
epsin, amphiphysin, and endophilin contain one or more AH motifs
which induce plasmamembrane invagination in a process orchestrat-
ed with scaffolding domains; e.g. BAR domain, dynamin or clathrin
oligomers [4–7]. Another cell function involving AH induction of
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AH segment of a protein such as Arf or Sar-1 is responsible for initiat-
ing a bud that will later become coated with a scaffold protein com-
plex, such as COP-1[4]. These AH elements can tubulate vesicles in
vitro when added at a high protein/lipid ratio (e.g. 1 AH motif/20
lipids). This process is typically monitored by electron microscopy,
where the AH causes long, thin protrusions from vesicles composed
of lipid mixtures from biological sources [4–7].
CTP:phosphocholine cytidylyltransferase (CCT), the rate-limiting
enzyme in PC synthesis, contains one of the longest membrane-
binding AH motifs that has been described [1,8]. CCT is subject to
regulation at many levels including regulation by amphitropism, i.e.
reversible membrane interactions [9]. In its inactive soluble form
CCT is silenced by a weak interaction between its catalytic domain
(C) and an auto-inhibitory segment (domain M) within its regulatory
tail region (Fig. 1A) [10]. In its active, membrane bound form domain
M adopts an AH structure (Fig. 1B) [8] and inserts into the bilayer of
membranes with PC-deﬁcient compositions. Activation of the
membrane-bound CCT rebalances the membrane PC content. PC ho-
meostatic control by CCT is observed in cells as an acceleration of
the CCT-catalyzed step and the overall rate of PC synthesis in re-
sponse to changes in cell membrane lipid compositions; for example
fatty acid [11] or diacylglycerol enrichment [12]. In vitro the activa-
tion of the pure enzyme can be monitored in response to lipid vesicles
enriched in anionic lipid, diacylglycerol, or PE [13–16]. The AH of
CCTα from rat is localized between residues ~234–300 [17]. Its
polar face is rich in charged residues, both basic and acidic side chains
form the interface between polar and non-polar helical faces [18], and
its non-polar face contains many bulky hydrophobic residues that
create a ~120° hydrophobic wedge for membrane intercalation
(Fig. 1B). Its helical hydrophobic moment (peak μH=0.69) is one of
the highest among characterized membrane-interacting AH motifs
[1]. The CCT β2 form also contains a conserved AH region, and di-
verges from the CCTα form only at the N and C-terminal ~50 residues.Fig. 1. (A) Domain structure of CCTα subunit indicating NLS (nuclear localization signal), th
(*) in region P substituted with glutamate in the PM variant. CCTα and β2 are highly conser
the NLS motif. (B). Domain M amphipathic helix (modeled from PDB 1pei and 1peh), with s
phobic sides chains; blue, basic; pink, acidic. The 3 glutamates are colored green (carbon) aThe AH of CCT resembles that of α-synuclein, the misfolding of which
is associated with the pathology of Parkinson's Disease. Both are very
long (70–90 residues [8,19]), contain a repeated 11mer sequence
motif [20], and their binding mechanisms are reliant on both electro-
static and hydrophobic driving forces, [1,13,18,19,21,22]. Synucleins
have been shown to both induce and sense membrane curvature
[23–25]. We sought to compare the membrane remodeling activities
of these two proteins in parallel.
Lagace and Ridgway [26] ﬁrst showed that over-expression of
CCTα can remodel membranes in cells. In that paper they reported
that not only the full-length CCTα but a variant missing the amphi-
pathic helical M domain was effective at inducing lipidic tubules in
CHO cell nuclei, where the alpha isoform was localized. Tubulation
by the constitutively active truncated construct was independent of
oleic acid treatment, which triggers membrane translocation of the
full-length CCT, and was suggested to be a result of massive phospho-
lipids synthesis driving membrane expansion. Somewhat incongru-
ously, expression of a catalytically dead full-length CCT induced a
proliferation of nuclear tubules, suggesting a curvature driving force
distinct from excessive synthesis and build-up of PC [26]. Mutations
in domain M which either increased or decreased membrane afﬁnity
were accompanied by large changes in membrane tubulation procliv-
ity in cells [27], implicating domain M in curvature induction. Lagace
and Ridgway [26] also showed that CCTα transforms vesicles into tu-
bules in vitro. Incubation of LUVs prepared from a complex synthetic
lipid mixture or total brain lipid extract with CCTα promoted the for-
mation of non-branching tubules with diameters in the range of
20–50 nm extending from the vesicles. The role of the M domain in
curvature promotion in vitro was not tested.
In the present work we used EM to study in detail the process by
which vesicular bilayers of various lipid compositions transform into
very thin tubules as the concentration of bound CCT increases. We
probed both lipid and protein determinants for this activity, and com-
pared the efﬁciency of different CCT forms and α-synuclein.e three glutamates (E) mutated to glutamine in domain M, the 16 phosphoserine sites
ved except for the N- and C-terminal regions indicated by the dashed lines. CCTβ2 lacks
tick rendering of side chains, residues 242–288 viewed down helix axis. Yellow, hydro-
nd red (oxygen).
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2.1. Materials
Egg PC and egg PG were purchased from Northern Lipids Inc.
DMPC, DMPG, POPE, POPS, PI, SM and brain total lipid extract were
from AvantiPolar Lipids Inc. The concentrations of phospholipid
chloroform stocks were determined with a phosphorus assay [28].
Thrombin Protease, and PreScission protease were from Amersham
Biosciences. Ni-NTA agarose was purchased from QIAGEN and
AcTEV Protease, from Invitrogen. Phenylmethylsulfonylﬂuoride,
Triton X-100, imidazole, n-octyl-β-D-glucopyranoside, 1,4-dithio-D-
threitol were obtained from Sigma-Aldrich. Formvar-carbon coated
grid (300 mesh) were from Electron Microscopy Sciences. The prepa-
ration of synthetic peptides corresponding to rat CCTα residues
236–268 (33mer peptide) and residues 237–293 (57mer-peptide)
was previously described [29].
2.2. Preparation of plasmids for transfection
Preparation of baculovirus vectors with the cDNAs encoding full-
length untagged rat CCTα isoform and CCTα236 (truncated at
codon 236) was described previously [15,30]. The construction of
vectors containing CCTβ2, CCTαΔNLS for expression in COS cells was
described in [31]. The CCTα3EQ cDNA [17] was transferred from a
COS cell-speciﬁc vector to the baculovirus vector pVL1393 using
existing or engineered sites; A XhoI/SstI fragment from modiﬁed
pGEX6p-CCTα236 [32] was transferred to similarly cut pVL1393-
CCTα3EQ to generate the 3EQ variant with an N-terminal GST tag
and a PreScission protease cite in the linker.
The CCT tail domain constructs were engineered by standard PCR
methods to contain thrombin-cleavable His6 tags. We used the fol-
lowing full-length CCTs as templates for mutagenesis: WT rat CCTα
[31], WT rat CCTβ2 [31], rat CCTα phosphomimic [33] (generously
provided by Dr. Neale Ridgway), or C. elegans CCT (ampliﬁed from a
C. elegans ORFeome library (ORF F08C6.2) provided by Dr. Nancy
Hawkins, using primers complementary to CCT sequences). The tails
were constructed to contain an NdeI site just upstream of the ﬁrst
codon and a Bam HI after the stop codon. The NdeI/BamHI CCT frag-
ments were inserted into the pET14b vector multiple cloning site
using NdeI and BamHI. The α-synuclein construct was prepared
with a thrombin-cleavable His6 tag by PCR using a template, PT7-7-
AS, provided by Dr. David Eliezer (Weill Medical School of Cornell
University). A NdeI site or XhoI site was engineered into the 5′ or 3′
primer, for ligation into NdeI/XhoI-cut pET14b.
2.3. Expression and puriﬁcation of CCTs and α-synuclein
The baculovirus-mediation expression and puriﬁcation of un-
tagged full length CCTα or CCTα236 was described in [14,29], and
the expression and puriﬁcation of His6-tagged CCTβ2 and CCTαΔNLS
from COS cells was described in [31]. The His-tag was cleaved with
TEV [34] and proteins were stored at −80 °C in 10 mM Tris, pH 7.4,
100 mM NaCl, 0.06 mM Triton X-100, and 2 mM DTT. GST-tagged
CCTα3EQ in the baculovirus vector pVL1393 was expressed and puri-
ﬁed from infected Trichoplusia ni cells via Glutathione-Sepharose af-
ﬁnity chromatography as described [32], with minor modiﬁcations
including a reduced Triton concentration (60 μM) in the ﬁnal wash
of the beads. To cleave the GST tag the beads with bound CCT were ro-
tated at 4 °C for 5 h with PreScission protease, in 50 mM Tris, pH 7.4,
1 mM EDTA, 150 mM NaCl, 0.06 mM Triton X-100, 1 mM DTT. Beads
and tag were removed by sedimentation. Tag-free pure CCT was
stored at −80 °C in the aforementioned buffer.
The CCT tail domains in pET14b vectors were expressed as His6-
tagged proteins in E. coli Rosetta strain. One-liter cultures were
induced with 1 mM isopropyl β-D-thiogalactoside. The inductiontimes and temperatures for the various constructs in pET14b were
as follows: CCTα WT tail, CCTα PM tail, CCTβ2 WT tail and C. elegans
CCT tail (2 h, 20 °C); CCTα M domain and α-synuclein (2 h, 37 °C).
Cells were collected by centrifugation at 3000×g for 10 min and
either stored at −80 °C or immediately resuspended in 100 ml of
lysis buffer (PBS pH 7.4, 1 mM DTT, 25 mM OG, 200 μg/ml Lysozyme,
10 μg/ml DNaseI, and battery of protease inhibitors including
Leupeptin (2.5 μg/ml), Chymostatin (2 μg/ml), Antipain (μg/ml),
Pepstatin (2 μg/ml), p-amino-benzadine (10 μg/ml), Benzamidine
(10 μg/ml), and phenylmethylsulfonylﬂuoride (0.5 mM). The sample
was then sonicated on ice for 4×15 s (with 15 s rests) with a Fisher
Sonic Dismembrator Model 300 at 30% output, followed by complete
lysis with an Avestin Cell Homogenizer Emulsiﬂex. The lysate was
centrifuged at 23,000× g for 30 min. The CCTs or synuclein were puri-
ﬁed from the supernatant via Ni-agarose afﬁnity chromatography as
described [31,34] except that the wash and elution buffers contained
25 mM octylglucoside. The buffer in the elution pool was then ex-
changed for PBS, 25 mM octylglucoside, 2 mM DTT using an Amicon
Ultra-4 (10,000 MWCO) centrifugal ﬁlter device at 25 °C (ﬁnal imid-
azole concentration was 10–20 mM). The ﬁltered protein was diluted
4-fold with PBS, pH 7.4, 2 mM DDT and the His tag was completely
cleaved with 1 unit thrombin per 50 μg CCT or synuclein at room tem-
perature for 7 h, with rotation. The thrombin reaction was quenched
with chymostatin, antipain, and leupeptin (2 μg/ml, 1 μg/ml, and
2.5 μg/ml respectively). The octylglucoside concentration was re-
duced to 0.1 mM via Amicon ultraﬁltration and buffer exchange,
which also removed the His-tag and concentrated the proteins. Puri-
ﬁed proteins were stored at−80 °C in PBS, 2 mM DTT, 0.1 mM octyl-
glucoside. Their concentrations were determined by absorbance at
280 nm and εM.
The accession numbers for CCTs used are as follows: rat
CCTα, P19836; rat CCTβ2, Q9Y5K3; C. elegans CCT, P49583; human
α-synuclein, P37840. The N-terminal linker sequences of puriﬁed,
tag-cleaved proteins were: GPLGSA for CCTα-3EQ, GRS for CCTβ2
and CCTα-ΔNLS, and GSHM for the CCT tails and α-synuclein.2.4. Large unilamellar vesicles (LUVs)
LUVs were prepared by extrusion of multilamellar vesicles at
room temperature (egg PC/egg PG and egg PC/oleic acid) or 37 °C
(DMPC/DMPG and NE mix) through two 100 or 400 nm polycarbon-
ate membranes (Lipofast Micro-extruder, Avestin, ON) [34]. LUVs, in
25 mM HEPES, pH 7.4, 100 mM KCl (EM) or 50 mM phosphate buffer,
pH 7.4 (CD), contained trace amounts of [3H] DPPC to quantify recov-
ery after extrusion. They were used immediately after extrusion.2.5. Sucrose-loaded vesicle binding assay
Binding of CCT constructs to sucrose–loaded large unilamellar ves-
icles (SLVs) was measured as described [16,31,34,35]. CCT (0.5 μM )
and varying amounts of DMPC/DMPG (1/1) SLVs were incubated for
10 min at 37 °C and sedimented at 100,000× g at 37 °C to separate
the vesicle-bound from the free protein. The intensity of the pellet
band was corrected for contamination by supernatant as well as pro-
tein that sedimented in the absence of SLVs [35]. The percentage of
bound protein was plotted as a function of accessible lipid concentra-
tion (1/2 of total lipid), and the data were ﬁt to the equation %Bound
protein=100 Kp[L]/(1+Kp[L]), where Kp is the molar partition coef-
ﬁcient. Kp is the reciprocal of the accessible lipid concentration
required to bind 50% of the protein [36]. Xb, the bound protein per
accessible lipid was calculated from the binding as described [37]:
Xb=(C0prot •XP,b)/CL, where C0prot is the total protein concentration,
XP,b is the mole fraction of bound protein, and CL is the accessible
lipid concentration (1/2 of total lipid concentration).
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Proteins or peptides (10 μM) in 0.22 μm ﬁltered 50 mM phosphate
buffer (pH 7.4), were incubated for 15 min at 37 °C without or with
DMPC/DMPG (1/1) 100 nm LUVs and CD spectra were recorded
using a Jasco-J-810 spectropolarimeter at 37 °C in a cell of 0.5 mm
path length at a scanning rate of 100 nm/min and a band width of
1 nm. Spectral resolution was 0.5 nm and 2 scans were averaged per
spectrum. All spectra were smoothed and corrected for the appropri-
ate backgrounds: buffer or buffer+LUVs at corresponding concentra-
tions for the lipid–protein samples. Molar ellipticity was expressed as
deg•cm2/dmol, and the protein concentrations were determined by
A280 nm and calculated extinction coefﬁcients (Expasy server). The
content of secondary structure was deconvoluted from the CD spectra
by CDPro and reference set 10, including 43 soluble and 13 mem-
brane proteins [38].2.7. Transmission electron microscopy
All solutions were ﬁltered through a 0.22 μm ﬁlter and all proce-
dures were done at 37 °C. LUVs (0.5 mM) in 25 mM HEPES, pH 7.4,
100 mM KCl were incubated in the presence or absence of protein
for 15 min (volume=20 μl). The total lipid/protein molar ratio varied
between 25 and 10,000. Samples containing the full length proteins
had 0.03 mM Triton X-100, and the CCT tail domains and synuclein
had 0.05 mM octylglucoside. The sample (5 μl) was placed on
Paraﬁlm “M” laboratory ﬁlm and a glow-discharged Formvar-carbon
coated grid (300 mesh) was placed on top of the sample and
adsorbed for 5 min. Excess liquid was blotted with Wattman ﬁlter
paper. For negative staining the grid was placed on top of three
drops of ﬁltered uranyl acetate (2 wt.%) and left for 30–60 s in the
last drop. Extra stain was blotted and grid was air-dried. Two grids
of each sample were examined. All micrographs were digitally
recorded (Gatan camera) in a Hitachi H-8000 STEM electron micro-
scope at 200 kV at direct magniﬁcation of 10,000–50,000. Images
were imported into Adobe Photoshop to measure vesicle and tubule
sizes.Fig. 2. CCTα promotes tubular extensions in vesicles composed of complex lipid mixtures.
posed of (A) brain total lipid extract extruded through 400 nm ﬁlters. Bars represent 200 nm
100 nm ﬁlters. Bars represent 100 nm. The molar ratio of CCT/lipid is indicated.3. Results and discussion
3.1. Remodeling of membranes by CCTα shows distinct pathways
depending on lipid composition
We monitored the CCT-induced morphological transformation of
vesicles by negative stain EM. While many lipid compositions sup-
ported vesicle tubulation, they differed in tubulation susceptibility
(CCT/lipid molar ratio required for tubulation), end point dimensions,
and also in the pathway of transformation.3.1.1. Remodeling of vesicles with complex lipid composition
Lagace and Ridgway [26] reported the CCTα- induced tubulation
of lipid vesicles (400 nm) composed of a total lipid extract from bo-
vine brain. In the absence of protein we found that these vesicles
had uneven surfaces and frequently showed membrane protrusions
(buds and short tubules; Fig. 2A, left panel). In agreement with the
earlier report [26] the addition of CCTα at a protein/lipid molar
ratio (P/L) of 1/100 or 1/50 increased the number of membrane pro-
trusions and promoted their growth into tubules, which occasionally
appeared to connect separate vesicles (Fig. 2A, right panel). The di-
ameter of the tubules emerging from the vesicles was 33±7 nm
(N=87, where N = number of unique tubules measured). The fre-
quency of tubule formation (vesicles with buds or tubules/total vesi-
cles) signiﬁcantly increased in the protein-incubated samples
from~6% in the absence of protein (N=467) to~46% at P/L=1/50
(N=294). Brain total lipid extract has a complex composition, with
59% unknown (Avanti Polar Lipids). Of the deﬁned components PE
is the dominant species (16.7%), PC is 9.6%, and the anionic lipid con-
tent is 15%, including PS (10.6%), PI (1.6%), and PA (2.8%). The acyl
chains are a mixture of saturated, mono and poly-unsaturated.
In many cultured and primary cells CCTα is nucleoplasmic
[39–41]. In CHO-K1 cells nucleoplasmic CCTα translocated to the nu-
clear envelope (NE) in response to oleate treatment and promoted
the proliferation of the nucleoplasmic reticulum network [26]. The
NE membrane contains various phospholipids that favor the forma-
tion of interfaces with zero, positive, or negative mean curvature.Electron micrographs of negatively stained vesicles (0.5 mM total phospholipid) com-
; (B) Nuclear envelope mix (PC/POPE/PI/POPS/SM (55/20/10/10/5) extruded through
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age distribution for the major phospholipids as follows: PC (54±8),
PE (21±8), PI+PS (16±5), SM (7±3); the anionic PL content
(PS+PI) ranges between 12 and 24 mol% [42–47]. We investigated
CCTα-induced tubulation of 100 nm LUVs composed of egg PC/POPE/
liver PI /POPS/eggSM (55/20/10/10/5) containing 20 mol% anionic PL
(NE mix), as a close mimic of a nuclear envelope bilayer. The protein-
free vesicles appeared soft, with numerous small buds (Fig. 2B, left
panel). As the concentration of CCTα was increased, the frequency
and length of the vesicle protrusions increased, similar to what was ob-
served with the brain-derived LUVs (Fig. 2B). The diameter of these tu-
bules at saturating protein concentration was 23±7 nm (N=113),
which is thinner than the brain system. These results suggest that
CCTα can induce vesicle tubulation of membranes with a physiologi-
cally relevant composition. This system along with the brain-derived
lipid vesicles provided clear evidence for the progression of tubes
from buds. Both systems have high PE content.
To test the importance of PE for the tubulation process, we
examined the tubulation activity towards DOPC/DOPE (2/3) LUVs
(100 nm), which have low bending energy (~5×10−20 J) [15] com-
pared to egg PC (8×10−20 J) or DMPC (24×10−20 J) [48], rendering
them more susceptible to deformations. However, although the
LUVs containing PE had surface protrusions that were common to
the other soft vesicles, we did not see an increase in tubes protruding
from these vesicles in the presence of CCT (data not shown). This is
likely due to the low binding afﬁnity of CCT for these vesicles,
which is 30-fold weaker compared to egg PC/egg PG (1/1) [16].
In these systems containing a heterogeneous mixture of head-
groups and chain unsaturation the morphologies of the pure vesicles
suggested soft, highly deformable surfaces. The buds could have been
generated during vesicle extrusion, via interactions with the solid
support on the EM grid, by effects of the stain or blotting the stain
from the grid, or they may have been due to an intrinsic material
property of the lipid mixtures. We note that other papers rarely com-
ment or show that the lipids from natural sources used to make
vesicles contain irregular surfaces, but in our experience this is a com-
mon observation in uranyl-stained TEM images. Regardless of the
mechanisms promoting vesicle blebs/buds, the long tubules emerging
from vesicles were clearly dependent on mixing vesicles with CCT in
solution. It is possible that CCT added to these malleable lipid systems
concentrates at locally deformed bud sites, which would enhance
their curvature to create tubules that emerge from the deformed sites.
3.1.2. Remodeling of anionic vesicles with homogeneous saturated acyl
chains
The binding afﬁnity of CCTα for vesicles composed of brain or
NE-mix lipids has not been studied. We sought a system for examining
tubulation activity by CCTα that could be coupled to binding strength
analyses. Moreover, to investigate the tubulation process and to com-
pare the tubulation activity of CCT variants we needed vesicles with a
lipid composition that lacked tubular protrusions in the absence of
CCT. 100 nm PC/PG (1/1) LUVs with dimyristoyl chains fulﬁlled this
criterion. We worked with these vesicles at 37 °C, well above the
Tm (23 °C), at all steps including the preparation of the EM grid.
These vesicles had relatively smooth surfaces and compared to the ves-
icles with mixed unsaturated chains they were much more regular
spheres (Fig. 3C, panel A). They often showed a collapsed central cavity,
but surface protrusions were absent. In the absence of added protein
these LUVs had an average diameter of 84±23 nm (N=224). This
lipid mixture was robust in that we consistently obtained grids for
TEM with high quality staining and ample material for observation.
CCT binds to PC/PG vesicles in proportion to the mol% PG [16,49]. The
electron micrographs in Fig. 3A reveal that, at similar P/L molar ratios,
tubulation increased and tubule size decreased with increasing mol %
PG. The data in Fig. 3A were used to construct a “phase” diagram for
the CCTα-induced vesicle to tubule transition (Fig. 3B). The diagramis based on the visual inspection of the micrographs and shows the
L/P molar ratio at which tubules were ﬁrst observed. It demonstrates
that tubulation correlates positively with anionic phospholipid content
and protein concentration. Sufﬁciently high levels of anionic lipid are
required to support strong binding and high membrane concentrations
of CCTα for vesicle tubulation.
Fig. 3C shows the progress of membrane remodeling of DMPC/
DMPG (1/1) 100-nm LUVs. CCTα binds to these vesicles with a high
partition coefﬁcient (8.3×104 M−1; derived from binding analysis
shown in Fig. 4A). Discrete tubules were ﬁrst observed at a CCT/
lipid ratio of 5000. At this CCT/lipid ratio there were a variety of
non-spherical shapes and tubules of ranging diameters, suggesting
that CCTα was not uniformly distributed among the vesicles
(Fig. 3C). The original vesicle population was heterogeneous with
diameters varying from 45 to 145 nm (data not shown). One can
envision CCTα binding preferentially to small vesicles with higher
curvature and promoting their deformation. An increase in CCTα con-
centration led to a relative decline in vesicle population and increase
of tubule number. Tubules also become thinner and more uniform in
size. For DMPC/DMPG (1/1) LUVs at P/L=1/50 almost all vesicles
were transformed into non-branching tubules of relatively uniform
diameter (average d=11.3±1.5 nm, N=194) and average length
L=253±87 nm, with a range from 100 to 500 nm (N=96). Fig. 3C
panel F shows the genesis of a thin tubule (d~10 nm) from the end
of a thick tubule (d~40 nm). In this phospholipid system CCTα did
not promote the formation of buds or tubules protruding from the
membrane surface; instead it changed vesicle shape uniformly.
These observations imply that CCTα likely remained homogeneously
distributed on the vesicle surface, and did not form discrete protein-
rich domains that can induce local membrane deformations, in con-
trast to the process observed with the mixed acyl chain systems.
We considered whether the saturated chains in the DMPC/DMPG
system were linked to the global remodeling mechanism. However,
two systems containing unsaturated chains, egg PC/egg PG (1/1)
and egg PC/oleic acid (1/1) also produced very thin tubules
(d=12.4±2.0 nm and 13.5±2.3 nm, respectively see Fig. S1), and
these did not appear to involve tubule emergence from vesicle-
associated buds. Thus chain saturation is not a critical factor deter-
mining the tubulation pathway.
3.1.3. The CCTα-remodeled particles are likely cylindrical bilayer tubules
with densely packed CCT
The extremely narrow diameters of the remodeled lipid particles
formed from PC/PG LUVs at high protein concentrations posed
questions about their structure. First we conﬁrmed that they were
lipid–protein complexes, and not purely lipidic or protein ﬁbers.
Fig. S2 shows that anti-CCT immunogold particles decorated the tu-
bules, and that the tubules generated with unsaturated egg PC/egg
PG (1/1) stain positively with osmium tetroxide, which stains by ox-
idizing the double bonds in lipids.
We then considered two possible structures: bilayer based tubules
or cylindrical micelles. The diameter of the DMPC/DMPG tubules in-
duced by CCT at a P/L of 1/50 was 11.3±1.5 nm. The precision of
this measurement is inﬂuenced by stain artifacts [50] and a 10%
error associated with calibration of the EM scales. The thickness of a
DMPC bilayer at 30 °C based on diffraction peak-to-peak separation
is 3.44 nm [51]. The polar head group region is ~1.0 nm wide and is
sufﬁcient to accommodate the CCT AH lying parallel to the surface
[52]. Accordingly, a tubule with a diameter of 11–12 nm could exist
as a cylindrical bilayer vesicle with a water-ﬁlled luminal diameter
of ~4–5 nm. Compared to a spherical SUV, a cylindrical tubule of sim-
ilar size has only one principal curvature (the curvature along the
long axis equals zero), and therefore a lower total curvature [53]. Ad-
ditionally, bilayer thinning upon insertion of AH segments is a well-
established phenomenon [54–56], and would reduce the curvature
strain in these narrow tubules.
Fig. 3. CCTα-dependent tubulation correlates with the anionic lipid content of DMPC/DMPG LUVs (100 nm). (A) Electron micrographs of negatively stained vesicles (0.5 mM) in-
cubated with protein at the indicated P/L molar ratios. Bars represent 200 nm. (B) “Phase” diagram for CCTα-induced vesicle-tubule transition in DMPC/DMPG LUVs (100 nm). Data
reﬂect the visual inspections of the electron micrographs in (A). The symbols indicate: (○)— lack of tubulation; (•)— tubules coexisting with vesicles; (ø )— vesicle coexisting with
occasional tubules. The dashed lines indicate the range for mol% anionic phospholipid in the nuclear envelope. (C) Progress of tubulation of DMPC/DMPG (1/1) LUVs by CCTα.
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the molar ratio of membrane bound CCT: accessible lipid (Xb). A bind-
ing analysis (Fig. 4A) provides the ratio of bound/unbound CCT as a
function of L/P ratios. Fig. 4B shows a plot of Xb as a function of
the total lipid: protein ratio and indicates saturation behavior when
Xb=~20 mmol CCT/mol lipid, or 1 CCT/50 accessible lipids. This max-
imal value for Xb is associated with thin tubules of 11–12 nm. We en-
vision that CCTα binds to the membrane surface through a 60–70
residue unbroken AH [8] ~10 nm long and 1 nm wide, and that one
third of its surface (the hydrophobic sector) inserts to make contact
with the acyl chains (Fig. 5). This computes to ~10 nm2 for the surface
area occupied by the inserted AH. Using a cross-sectional area for
DMPC of 0.6 nm2 [57], approximately 12 phospholipids will line a
helix 10 nm long on either side, thus a minimum of 24 lipid moleculesare required for binding. Therefore the CCT packing density on the
narrowest tubules (1/50), calculated from the binding curves, does
not exceed the limits of the steric requirements for a tightly packed
lipid/protein assembly (1/24).
For a tubule fully saturated with the CCT AH one-half of the lipid
on the outer leaﬂet would be in contact with an AH segment, whose
long axes run parallel to the tubule long axis. The entire outer
monolayer would be thinned as much as 0.5 nm [56], to generate a
larger internal volume (see Fig. 5). Such highly curved structures
(10–15 nm) have been detected by negative stain EM for tubules in-
duced by the HEL13-5 helix [58] or α-synuclein [23]. Endophilin
and Yop1p-induced tubules, observed by cryo-EM or negative stain,
also had small diameters of ~15 nm when saturated with protein
[59,60].
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Fig. 4. (A) Binding of CCTα to DMPC/DMPG (1/1) SLVs (100 nm) at 37 °C. Data were
compiled from two independent experiments. (B) The membrane bound density of
CCTα (Xb; in units of mmol CCT/mol accessible lipid) was calculated from the binding
curves as described in Materials and methods, and plotted as a function of the total
lipid/protein molar ratios.
1179S.G. Taneva et al. / Biochimica et Biophysica Acta 1818 (2012) 1173–1186The alternative hypothesis, that CCTα-induced tubules could rep-
resent cylindrical micelles, is less likely. Cylindrical micelles generat-
ed by endophilin [59], or detergent [61,62] have diameters of only
3–5 nm, which are considerably lower than the average diameter of
CCTα-induced tubules and of the diameter of the smallest tubules
we observed (9 nm). Moreover, we would expect that the conversion
of vesicle bilayers to micelles would be associated with an abruptFig. 5. Model of multiple CCT AH segments coating a tubule. A section of a bilayer
tubule of 12 nm diameter showing dimensions of the tubule and the CCT AH (gray
cyllinders) approximately to scale. There are two layers of phospholipids per AH
with ~12 lipids lining the AH on either side. The bilayer width has been thinned to
3.5 nm by packing distortions induced by the embedded AH. ~12 AH pack around the
circumference of the tubule. This stoichiometry would correspond to the situation in
Fig. 4b where Xb=20 and there is 1 CCT/50 lipids in the outer layer. The presence of
the adjoined catalytic domain (not shown) would inﬂuence the CCT spacing.leakage of internal contents. We found however, that the leakage of
carboxyﬂuoroscein from egg PC/egg PG vesicles induced by CCT was
gradual and was nearly complete prior to the onset of tubulation;
i.e. leakage did not correlate with the appearance of the very thin tu-
bules (Fig. S3). This gradual leakage during tubulation can account for
the observed ~10-fold loss in volume (mean volume of vesicles,
270,000 nm3; mean volume of tubules at endpoint, 28,000 nm3). De-
spite the volume loss, the lipid surface area was relatively well con-
served (mean S.A. of vesicles, 20,000 nm2; mean S.A. of tubules,
10,000 nm2).
3.2. The domain M amphipathic helix is necessary and sufﬁcient for
tubulation
3.2.1. The CCT tail is required for vesicle tubulation
All CCTs examined rely on their AH motif for membrane binding
[31,34,63,64]. To clarify the importance of the amphipathic helical
domain M in the induction of membrane curvature we compared
the tubulation activity of full-length CCTα with that of a truncated
version lacking the entire tail, including domain M and P (Fig. 6).
While addition of full-length CCTα drastically changed vesicle shape
and caused massive tubulation, CCTαΔ236 did not affect vesicle
morphology. Thus CCTα in vitro tubulation activity requires its tail,
suggesting a key involvement of its AH motif.
3.2.2. A mutation in domain M that enhances binding strength enhances
tubulation activity
Three interfacial glutamates in domain M, E257, E267, and E279,
serve as determinants of CCT membrane afﬁnity [18]. Protonation of
these glutamates increased the hydrophobicity and reduced the an-
ionic lipid selectivity for membrane binding of a 33-mer peptide
based on residues 256–288. Mutation of the three glutamates to glu-
tamines (CCTα3EQ) mimics interfacial protonation. This effect en-
hanced the membrane partitioning of CCTα3EQ expressed in COS
cells [18]. When over-expressed in CHO58 cells CCTα3EQ promoted
the formation of nuclear membrane tubular networks with the
protein bound to these tubule bundles [27]. When we compared the
tubulation activity of WT CCTα vs CCTα3EQ towards LUVs composed
of DMPC/DMPC (1/1) we found only a slight augmentation of tubula-
tion efﬁciency for the 3EQ variant at lower P/L ratios (Fig. 7A).
Tubules were apparent at P/L=1/5000 for WT CCT and at 1/10 000
for 3EQ. Binding to DMPC/DMPG (1/1) vesicles was very similar
for the WT and 3EQ variant (Fig. S4), with partition coefﬁcients of
8.3±1.9×104 M−1 and 6.9±13×104 M−1, respectively. However
the tubulation activities of the two CCTs could be distinguished
using LUVs with a lower anionic lipid content. LUVs with 20% DMPG
showed clearly that the 3EQ variant had stronger remodeling activity
(Fig. 7B; Table S1). This is in keeping with its increased positive
charge and hydrophobicity, and its lower anionic lipid requirement
for membrane binding. Binding of both CCTs to the LUVs resulted in
gradual vesicle morphology change with increased numbers of tu-
bules and decreased tubule diameter. However, at high protein con-
centrations (P/L>1/500) corresponding to protein excess (Fig. S4A),
we observed fragmentation of tubules by CCTα3EQ (compare panels
B4 and B5 with panels A4 and A5 in Fig. 7A). This property may reﬂect
the increased hydrophobicity of the glutamine-containing M domain.
3.2.3. The NLS segment is not required for vesicle tubulation
In addition to the AH motif some CCTs, including mammalian
CCTα, contain a secondary membrane binding motif, the N-terminal
NLS segment. This sequence (12RKRRK16 in CCTα) supports vesicle
cross-bridging [34] and contributes to the electrostatic membrane
binding energy [31]. We investigated the contribution of the NLS
sequence to vesicle tubulation in CCTα using a mutant with the NLS
sequence deleted (CCTαΔNLS) and a CCT isoform lacking the NLS
(CCTβ2).
Fig. 6. Tubulation of vesicles requires the C-terminal regulatory tail region of CCTα. Electron micrographs of negatively stained DMPC/DMPG (1/1) LUVs (100 nm) in the absence of
protein (A) or incubated with full length CCTα (B) or with CCTα236 deletion mutant lacking the C-terminal tail region M+P (C). Vesicle and protein concentrations were 0.5 mM
and 20 μM, respectively.
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DMPC/DMPG (1/1) LUVs compared to CCTα. At P/L ≤ 1/500 thicker
and shorter tubules were present in comparison to CCTα (Fig. 7A).
The average tubule diameter at P/L=1/100 was signiﬁcantly larger
for vesicles incubated with CCTαΔNLS (13.3±5.1 nm) compared to
CCTα (11.7±3.4 nm) (t-test; p=0.0004).
We compared the binding to the same LUVs (Fig. S4A) and calcu-
lated the partition coefﬁcients for CCTαΔNLS (0.4±0.2×104 M−1)
and CCTβ2 (0.6±0.3×104 M−1), compared to 8.3±1.9×104 M−1
for the WT CCTα. The membrane concentrations (Xb) of the proteins
were calculated from the binding curves and plotted as a function of
the total L/P molar ratio in Fig. S4B. At L/P>1000, corresponding to
100% bound protein, Xb was similar for all proteins. For L/Pb500
both proteins had considerably lower Xb compared to CCTα consis-
tent with their lower binding afﬁnities. The weaker tubulation activ-
ity of the CCTs missing the NLS segment is thus consistent with
their lower membrane concentrations at high P/L ratios. These data
suggest that the NLS segment is not required for tubulation but con-
tributes to the tubulation efﬁciency of CCTα by supporting strong
membrane binding and high membrane concentrations. At equivalent
membrane concentrations (Xb≅0.7 mmol protein/mol accessible
lipid) corresponding to P/L~1/3000, tubulation intensity appeared
similar for CCTα and CCTαΔNLS. Thus at similar membrane density
the presence of the NLS did not appear to contribute to the tubulation
efﬁciency.
At higher protein concentrations, (P/L≥1/500), CCTβ2 fragmented
vesicles and tubules into small particles (Fig. 7A, panels D4, D5). This
observation was unexpected given that the membrane concentra-
tions of CCTβ2 were considerably lower compared to CCTα at these
P/L ratios (Fig. S4B). The stronger lysing activity of CCTβ2 is supported
by dye-release measurements (Fig. S3). This fragmentation activity
was not seen for CCTαΔNLS, which has a partition coefﬁcient similar
to CCTβ2. Therefore it is unlikely due to the loss of the NLS.3.2.4. Domain M is sufﬁcient for vesicle tubulation
To test whether the AH region of CCTα is sufﬁcient for its mem-
brane remodeling function we compared the tubulation activity of
the complete tail domain (domain M+region P, residues 237–367;
designated (M+P)α) and an 84mer fragment composed solely of
the entire M domain (residues 231–314; designated Mα) with that
of full-length CCTα. The tubulation activity of the (M+P)α fragment
toward DMPC/DMPG LUVs was approximately the same as that of
CCTα (compare Figs. 7A and Fig. 8A). Tubules became evident at P/L
of 1/~5000, and vesicle tubulation was virtually complete at P/L ratios
of 1/100. Also, the tubule diameters at saturation were nearlyFig. 7. (A) Comparison of vesicle tubulation by CCT isoforms and variants. DMPC/DMPG (
CCTα3EQ wherein E257, E267, and E279 in the membrane binding domain M were repl
12RKRRK16 (C); CCTβ2 (D). Lipid concentration was 0.5 mM. Scale bars are indicated on
LUVs (100 nm). Scale bar is 200 nm.identical, 11.3±2.8 nm and 11.7±3.4 nm. Thus, the complete CCTα
tail region appears to be as strongly curvature inducing as the full-
length CCTα. The tubulation activity of the Mα fragment was some-
what less than the full tail domain in that ~3-fold higher P/L ratio
was required to generate detectable tubules (Table S2). However,
the thickness of the tubules at high P/L was ~identical to those gener-
ated by the complete tail or full-length CCTα (11.7±1.8 nm;
N=155), suggesting strong curvature promotion by the 84mer M
fragment (Fig. 8, panels A and B).
3.2.5. Helix length inﬂuences the tubulation of vesicles by the AH of CCTα
A synthetic 57mer peptide corresponding to residues 237–293 of rat
CCTα required ~10-fold or 30-fold higher protein concentration to ini-
tiate tubulation of the LUVs compared to the 84mer M fragment or
the full CCT tail (see Fig. 8, panel C; Table S2). At P/L ratios>1/100,
the tubules were a mixture of some thick (36.3 nm±16.8 nm,
N=209)) but mostly thin (11 nm) diameters. A 33mer domain M pep-
tide (residues 236–268) did not tubulate even when mixed with the
LUVs at a P/L of 1/25. One would predict that tubulation should corre-
latewithmembrane binding strength and the AH content of bound pro-
tein/peptide. CD analysis of the synthetic domainMpeptides has shown
that anionic lipid vesicles promote a conformational switch from amix-
ture of secondary structures to predominantly α-helical structure
[29,30,65]. Acquisition of helical content correlates very well with
other measures of binding [18,29]. Deconvolution of CD spectra provid-
ed the fractional helical content with increasing lipid concentration
(Fig. 9; Table S3). The complete tail fragment and the M fragment
showed similar lipid responses, whereas the 57mer's response was
~3-fold weaker. At saturating lipid concentration the fractional helical
contents indicated helix lengths of ~70 (M+P), 58 (Mα 84mer), 24
(Mα 57mer) and 4 amino acids (Mα 33mer). Thus tubulation efﬁciency
relies on folding of an α-helical segment long enough to provide the
binding energy required for high membrane concentrations. But in ad-
dition, since highly curved tubules have many small hydrophobic pack-
ing defects, longer helices could provide a continuous hydrophobic face
around which small packing defects coalesce [66]. In this way longer
AHs could stabilize tubules of longer length.
3.2.6. Differential membrane-remodeling properties of the tail domains
of CCTα and CCTβ2
The tubulation activities of the tail portions (M+P)α and (M+P)β2
were similar up to~P/L=1/100 (Fig. 8), in keeping with their similar
L/P ratios for binding and alpha helical contents at saturation (Fig. 9;
Table S3). However, at higher protein concentrations of (M+P)β2
(e.g., P/L=1/45), short membrane fragments coexisted with tubules1/1) LUVs (100 nm) were incubated at the indicated P/L molar ratios with CCTα (A);
aced with glutamines (B); CCTαΔNLS, a deletion mutant lacking the NLS sequence
panels. (B) CCTα3EQ displays enhanced tubulation efﬁciency in DMPC/DMPG (4/1)
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Fig. 8. The membrane binding domain of CCT is sufﬁcient for vesicle tubulation. DMPC/DMPG (1/1) LUVs (100 nm) were mixed with the various CCT segments and the indicated P/L
molar ratios. Phospholipid concentration was 0.5 mM. Scales are indicated on the panels. Arrow in panel C4 indicates a vesicle transforming into a tubule.
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(Fig. 7A) and barrier disruption (Fig. S3) observed with full-length
CCTβ2.
The properties of the AH region of (M+P)β2 and (M+P)α are
very similar up to ~residue 298 [31] and are unlikely to account for
the observed differences in membrane remodeling. The P regions in
both enzymes are very polar and thus unlikely to embed into lipid bi-
layers. However, the hydrophobicity of the 15 residue segment be-
tween residues 298–312, just preceding the P region, is greater in
CCTβ2, with the two leucines in CCTα replaced with a tryptophan
and a phenylalanine in CCTβ2. Participation in membrane binding
by this segment is supported by lipid vesicle-induced ﬂuorescence
blue-shifts of a (M+P)α variant containing a single tryptophan at
position 302 and insensitivity to aqueous phase ﬂuorescence
quenchers (data not shown). Thus, membrane destabilization by
CCTβ2 may result from strong hydrophobic interactions and disrup-
tion by the aromatic residues occupying a greater volume withinthe monolayer. Substitution of aliphatic residues with Trp in tubule-
inducing alpha helices has been reported to cause tubule and vesicle
fragmentation [5,67].
3.2.7. The C-terminal tail domain of CCT from C. elegans induces vesicle
tubulation
CCT from C. elegans has a similar domain structure to the mamma-
lian CCTs. It is a lipid-activated enzyme and a segment C-terminal
to the catalytic domain, predicted to be α-helical, was crucial for
lipid activation [63]. The segment between residues 220–281 of the
C. elegans CCT shows similarity with domain M of rat CCTα, but is
missing an 18 residue segment corresponding to residues 252–269
of the rat CCTs, or exactly 5 α-helical turns. Ten-fold higher concen-
trations of the tail domain from C. elegans were required to initiate
tubulation of DMPC/DMPG (1/1) LUVs (P/L=1/900) vs. 1/9000 for
the rat CCT tail (Table S2 and Fig. 8, panel E). Moreover, the tubules
induced by the C. elegans CCT tail were thicker at P/L≥1/90
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Fig. 9. Lipid-induced increase in the helical content of peptides based on (M+P) do-
main of CCTs and α-synuclein. Peptide CD spectra were measured in the presence of
DMPC/DMPG (1/1) LUVs (100 nm) at 37 °C and were deconvoluted using the CDPro
software. Peptide concentration was 10 μM.
1183S.G. Taneva et al. / Biochimica et Biophysica Acta 1818 (2012) 1173–1186(d=14.1±5.3 nm, N=250 ). Thus the tubulation activity of this
shorter amphipathic helix was reduced rather drastically. This effect
could not be explained by weaker binding of the C. elegans AH
(Fig. 8; Table S3), but could reﬂect a shorter AH length. CD measure-
ments of (M+P) C. elegans conﬁrmed that partitioning into DMPC/
DMPG (1/1) LUVs was accompanied by an increase in the helical con-
formation from 5 to just 36% (Fig. 9B and Table S3), corresponding to
44 amino acids in a helix conformation, compared to ~70 for rat
CCTα.
3.2.8. α-Synuclein has a weaker tubulation activity than the CCT tail
α-Synuclein, like CCT, contains a very long membrane binding AH
followed by a disordered acidic tail. While this study was under way a
paper describing the vesicle tubulation activity of α-synuclein was
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Fig. 10. Comparison of the tubulation of α–synuclein with the CCT tail. DMPC/DMPG (1/1
a phosphomimic variant of the CCT tail with 16 serine residues in the P region substitute
are indicated on the panels.with the tail domain of CCTα in its unphosphorylated or phosphomi-
mic (PM) versions. The latter was created by substituting glutamate
for each of the 16 serines in domain P that are known to be at least
partially phosphorylated in animal cells [17,33,68,69]. The phospho-
mimic version of the CCT tail more closely resembles α-synuclein,
which contains 15 acidic residues in the segment C-terminal to the
AH motif. The membrane afﬁnities and tubulation activities of the
PM and unphosphorylated tail CCT tails toward DMPC/DMPG (1/1)
LUVS were similar, except that the PM tail induced vesicle fragmenta-
tion at high P/L. Higher concentrations of α-synuclein (P/L=1/360
compared to P/L=1/5000) were required to initiate tubulation
(Fig. 10). Moreover, the tubules generated by α-synuclein were
thicker (21.9±4.1 nm (N=198) compared to 12.0±2.5 nm
(N=183) for CCT(M+P)α PM at very high protein concentrations,
e.g. P/L=1/90. CD measurements were consistent with a ~3.5-fold
weaker membrane partitioning of α- synuclein compared to
(M+P)α PM (Fig. 9B; Table S3), and this may reﬂect a stronger
requirement for small curved vesicles by α-synuclein [24]. But this
difference in binding afﬁnity would not appear to account for the
>10-fold reduced tubulation activity of α-synuclein.
4. Concluding discussion
The membrane remodeling activity of CCTα in cells has been pre-
viously demonstrated after induced translocation by oleate and/or by
over-expression of CCTα [26,27]. We present a systematic EM analy-
sis of the formation of lipid nanotubules induced by CCT in vitro, and
show that the membrane remodeling function is imparted by the CCT
AH motif. From the morphology changes during CCTα titrations we
deduce that CCTα can transform vesicles into nanotubules via two
distinct mechanisms depending on the curvature uniformity of
the initial vesicle surface, which is inﬂuenced by phospholipid
composition.
(1) The bud extension pathway:When the vesicle composition has
a potential for demixing, e.g. a diverse assortment of acyl
chains and headgroups as in the brain or NE mixture, CCT ap-
pears to extend the small protrusions present on the soft vesi-
cle surfaces into thick tubules of 23–33 nm diameter. CCT
concentrates preferentially at deformation sites, amplifying
the curvature effect. Membranematerial will ﬂow into the pro-
truding tubule from the rest of the vesicle. The projections
emerging from the heterogeneous vesicles never transformed
into thin 11 nm tubules likely because the CCT density was
limiting, as the binding afﬁnity is low for lipid systems with1/90 1/45
       100 nm           100 nm             
      100 nm         100 nm 
    A3                        A4 
     B3                        B4 
) LUVs (100 nm) were incubated at the indicated P/L molar ratios with (M+P)α PM,
d with glutamic acid (A), or α-synuclein (B). Lipid concentration was 0.5 mM. Scales
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buds was observed when apolipoprotein A1 amphipathic
helix was added to MLVs composed of a simple PC/PG mix, so
a heterogeneous lipid system is not a prerequisite for this path-
way. MLVs have highly deformed surfaces [70] to promote
budding, and protruding buds may be stabilized by a large ma-
terial reservoar.
(2) The global remodeling pathway: CCT promoted global (uni-
form) vesicle transformation into tubules in ideally mixed
phospholipid systems containing ≥15 mol% anionic PL that
supported strong bilayer partitioning and high protein mem-
brane concentrations. CCT likely binds uniformly as these
vesicles lack compositional and morphological heterogeneity.
The bud extension pathway would be the more prevalent
pathway in cell membranes, which have high potential for
demixing and non-uniform curvature. However, we note that
over-expression of a constitutively membrane bound form of
CCTα within CHO cell nuclei induced the accumulation of
stacks of thin lipidic tubules (10–20 nm diameter) decorated
with CCT [27], suggesting that the global remodeling pathway
can operate in cells under conditions of very strong CCT-
membrane afﬁnity.
These two tubulation mechanisms are reminiscent of the two
schemes for curvature induction discussed by Campelo et al. [3]. The
bud extension mechanism is equivalent with the laterally uncoupled
mechanism proposed in that paper, in that both rely on localized clus-
tering of the bound curling agent, such as an AH motif. The global
pathway is equivalent to the laterally coupled mechanism, in that
both rely on a uniformly distributed AH motif over an individual ves-
icle surface. Although the CCT distributes fairly evenly over a single
vesicle, there is evidence for target selection during remodeling via
the second global pathway. In samples where the DMPC/DMPG was
in high excess over protein untransformed vesicles commonly co-
existed with very thin tubules (see Figs. 3A, C, 7A). It is reasonable
to assume that this reﬂects a heterogeneity in the density of CCTs
among the possible binding targets, with a lower density of CCT on
a vesicle or thick tubule than on a thin tubule in any sample. What
is the basis of the discrimination of one particle over another? One
possibility is that after CCTs bind to a vesicle the developing curvature
directs subsequent CCTs to select this target while rejecting a CCT-
deﬁcient vesicle with a ﬂat surface. In this way CCT-induced tubula-
tion exhibits positive cooperativity. In a separate study we have
found that the CCT AH can function as a curvature sensor in addition
to a cuvature inducer (Chong, S., Lee, J., Taneva, S.G., Ding, Z., Cornell,
R.B., unpublished).
The membrane-binding lipid-induced AH domain was necessary
and sufﬁcient for the curvature-inducing properties of CCTα. The sec-
ondary membrane-binding domain, the NLS segment, was not re-
quired for tubulation. The parameters we considered to be relevant
for curvature induction by the CCT AH included binding strength/
density of AH on the membrane, helical length, hydrophobicity of
the inserted face of the AH — which is related to the degree of lipid
displacement, and the position of the AH along the bilayer normal.
Tubulation activity correlated strongly with helical length (Fig. S5),
and poorly with binding strength, measured by the L/P ratio required
for half maximal alpha helix induction (Tables S2 and S3). For exam-
ple, the rat CCT tail domain, the rat CCT M fragment, and the tail from
C. elegans, had similar binding afﬁnities, but very different tubulation
activities that correlated with the number of α-helical turns mea-
sured by CD (20, 16, and 12, respectively). While helical length corre-
lates with hydrophobic binding energy, this is only one component of
the total binding free energy [71], thus it is not surprising that there is
a poor correlation between helix length and binding afﬁnity. We sug-
gest that tubulation is connected to helical length in that when a very
long AH is created on a membrane it will impart an axis to thecurvature that will inﬂuence the direction of binding of a subsequent
helical segment. The longer the AH motif, the less likely that it will
align randomly with respect to the curvature axis, and the more effec-
tive it will be at establishing a long thin tubule. This cooperative effect
of AH binding could account for the non-linear relationship between
helix length and tubulation efﬁciency, shown in Fig. S5.
The correlation between helical length and tubulation activity was
not apparent when comparing the rat CCT tail and α-synuclein, both
of which have 20 turns when membrane bound. Also, the weaker
tubulating activity of α-synuclein could not be fully accounted for
by its diminished partitioning constant, which was only b4-fold
lower than that of the CCTs. At a P/L ratio of 1/1000, the molar density
(Xb) of the CCT tail and synuclein are the same (they are both 100%
bound), but only CCT generated tubules. We speculate that the differ-
entiating feature relates to the position of the CCT tail vs α-synuclein
in the bilayer. Jao et al. [72] used site directed spin labeling to esti-
mate a positioning for α-synuclein helical axis just below the level
of the phosphates in SUVs. The effects of spin labels on the NMR sig-
nal broadening suggested that micelle-bound α-synuclein also ap-
pears to sink into the acyl chain region [73]. The positions for the
CCT AH peptides are not well resolved [65]. The AH of α-synuclein
has a less charged polar face than the AH of CCT and a larger angle
for the non-polar face that may allow it to sink more deeply into
the bilayer, where it would have a relatively weaker asymmetric
stress [3].
The property of CCT to induce membrane curvature is a relatively
new aspect of the membrane interactions of this lipid biosynthetic
enzyme. CCTα and β2, through their function in the regulation of PC
synthesis, have been implicated in the biogenesis and morphology
of organelles such as the nucleoplasmic reticulum [26] and the ER
[74], and in neurite outgrowth and branching [75–78]. However,
their function in the regulation of PC synthesis does not offer
an explanation for roles in direct membrane deformation. The
membrane-binding function of CCTα, independent of its catalytic
function, promoted the expansion of the nucleoplasmic reticulum tu-
bules in CHO58 cells and thus demonstrated a membrane-remodeling
property of CCT in a cellular context [26,27]. Although it was
subsequently shown by inhibiting expansion of the NR that it is not
a signiﬁcant site of PC synthesis [79], the nuclear envelope remodel-
ing function of CCTα may contribute to other functions of the NR,
such as nuclear compartmentalization and nuclear-cytoplasmic com-
munication [80].
Although CCTα is predominantly nuclear in CHO cells, in many
cells CCTα, like CCTβ, is cytoplasmic and shuttles on and off the ER.
The ER morphology is highly dynamic/malleable, The rough ER is a re-
ticular network featuring zones of both high positive and negative
curvature [81]. CCT's binding to the ER would activate the enzyme
to stimulate PC synthesis and simultaneously assist in maintaining
the reticular architecture of the ER. Thus the remodeling function of
CCTs may be of importance when CCT is activated by binding to the
ER. In support of a role for CCT in ER remodeling, Testerink et al.
[74] found that in CHO cells temperature sensitive for CCTα expres-
sion the reticular ER became more spherical, and dilated at the non-
permissive temperature. They attributed this to a decrease in PC
content, but it remains a formal possibility that it is due to lack of
the reticulating function of the AH motif in CCTα or CCTβ.
Lastly, the CCT AH contributes to maintenance of small lipid droplet
morphology in cells. Very recently Krahmer et al. [82] showed that CCT-
binding to lipid droplets via its AH prevents the growth (coalescence)
of small lipid droplets into larger ones during triglyceride loading of Dro-
sophila S2 cells. They attributed this to the PC-synthesis promoting func-
tion of CCT, but their own data showing that a constitutively active CCT
missing the AHdomainwas ineffective at restoring normal LD phenotype
in CCT1-depleted S2 cells argues that something more than the PC-
generating function of CCT was at work. We suggest that the surfactant
activities of both PC and the CCT AH [29] stabilize small curved droplets.
1185S.G. Taneva et al. / Biochimica et Biophysica Acta 1818 (2012) 1173–1186While, the biological function of CCT-mediated membrane defor-
mations remains to be established, we have shown here that the
long CCT AH is extremely potent, inducing curvature stress at very
low membrane densities. We anticipate that this versatile lipid
biosynthetic enzyme may play a dual role in cellular membrane mor-
phogenesis by both initiating/stabilizing membrane deformations
and stimulating local production of PC required for the differentiation
at these sites. A connection between membrane phospholipid
biosynthesis and membrane curvature has also been proposed for a
yeast phosphatidate phosphatase [83], but CCT is the only example
of a lipid synthetic enzyme for which this dual action has been
demonstrated.
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